Jenoptik Earnings Call: Mixed Year, Cautious 2026 Optimism

Jenoptik AG ((DE:JEN)) has held its Q4 earnings call. Read on for the main highlights of the call.

Jenoptik’s latest earnings call painted a mixed picture for investors, blending solid operational progress with clear near‑term headwinds. Management highlighted new capacity, strong niches, and tighter cost control, but also acknowledged falling group revenue, weaker semiconductor demand, and lower earnings for 2025, leaving sentiment cautiously constructive rather than outright bullish.

Micro‑Optics Fab Commissioned in Dresden

Jenoptik brought its largest single investment, the new micro‑optics fab in Dresden, fully online, marking a major milestone for the group. The facility significantly expands capacity for micro‑optics used in data communication and AI‑driven applications, positioning the company to capture structural demand growth in these high‑speed, data‑heavy markets.

Biophotonics Delivers Strong Growth and Margins

The Biophotonics business posted an impressive year, with order intake rising about 19% and revenue up roughly 10% year‑on‑year. Growth was driven by defense and life science applications, while the EBITDA margin climbed above 20%, reflecting better factory utilization and a more profitable product mix.

Smart Mobility Builds Traction with Margin Expansion

Smart Mobility showed solid momentum, as revenue increased almost 9% in 2025 and order intake grew in the mid‑single‑digit range. Profitability improved sharply, with the margin expanding by more than 200 basis points to 13.6%, supported by an expanded go‑to‑market approach and a larger service footprint in the U.S. market.

Semiconductor Inspection Resilient Amid Lithography Weakness

Within the semiconductor portfolio, the inspection business remained a bright spot, recording strong customer activity and revenue growth even as lithography demand softened. As a result, the broader semiconductor segment still delivered a robust full‑year EBITDA margin of around 26%, climbing to roughly 29% in the second half and underlining its resilience.

Cash Generation Strengthens Balance Sheet

Jenoptik’s cash profile improved markedly, with operating cash flow before tax rising significantly and free cash flow increasing by nearly EUR 50 million. This allowed the company to reduce debt and leverage, while capital expenditure normalized and is expected to run slightly below the prior year as spending shifts toward maintenance levels.

Efficiency Program and Headcount Reduction

Management pushed ahead with a broad efficiency and cost‑reduction program, introducing a leaner organizational setup across the group. Full‑time equivalent headcount fell by almost 5% year‑on‑year, which helped protect margins and free up cash despite the weaker top line and rising labor cost pressures.

Incremental Returns to Shareholders

Despite declining earnings, Jenoptik proposed a higher dividend of EUR 0.40 per share for fiscal 2025, up from EUR 0.38 the year before. The move signals confidence in the company’s cash‑generation profile and its willingness to maintain a shareholder‑friendly capital‑allocation stance in a choppy operating environment.

Group Revenue Under Pressure

At the group level, revenue slipped by about 6% year‑on‑year to around EUR 1.05 billion, with currency effects, mainly EUR‑USD, knocking roughly one percentage point off growth. The decline underscores the impact of softer demand in key areas, particularly in semiconductor lithography, and confirms that 2025 is a transition year.

Order Intake and Backlog Slide

Group order intake fell around 3% compared with the prior year, pushing the book‑to‑bill ratio down to 0.95 and reducing the order backlog to about EUR 591 million. Management expects to convert more than 80% of that backlog into 2026 revenue, but the slower intake signals a more cautious demand backdrop.

Semiconductor Segment Downturn Weighs on Results

The Semiconductor & Advanced Manufacturing segment faced a pronounced downturn, with order intake down about 11% and revenue off roughly 12% year‑on‑year. The drop was driven mainly by weaker lithography demand and supply‑chain fluctuations, making this business the main drag on group growth despite solid inspection activity.

Profitability Compression at Group Level

Group EBITDA declined to nearly EUR 193 million, down about 13% from the previous year, as the margin contracted by roughly 150 basis points and gross margin by about 130 basis points. Lower fixed‑cost absorption, due to reduced volumes, and an adverse business mix were key contributors to the profitability squeeze.

Earnings and ROCE Move Away from Ambitions

Earnings per share dropped to EUR 1.26 from EUR 1.62 a year earlier, reflecting both weaker operating profit and higher cost burdens. Return on capital employed slipped to 8.4%, well below Jenoptik’s medium‑term ambition, highlighting the profitability challenge posed by the current cyclical downturn.

Prodomax Weakness Highlights North American Risk

Automation specialist Prodomax saw a mid‑single‑digit order cancellation in the fourth quarter of 2025 and experienced generally low order intake. Management noted that demand from North American OEMs remains volatile and subdued, creating a risk that continued depressed volumes could further pressure profitability in this unit.

Market and Phasing Risks Heading into 2026

Management cautioned that revenue in the first quarter of 2026 will be lower than in the prior‑year period, mainly because of order phasing and capacity availability. Broader macroeconomic and geopolitical uncertainty, combined with an expected roughly 1 percentage point foreign‑exchange headwind, could add further pressure to near‑term results.

Labor Cost Inflation and Restructuring Headwinds

Jenoptik is also bracing for cost headwinds from a German labor agreement implying around 3% higher wages from April 2026, together with lingering inflation and energy‑price risks. Although prior restructuring triggered one‑off expenses in the high single‑digit million range, these are set to fade, allowing the cost‑savings program to show through more clearly.

Forward‑Looking Guidance and 2026 Outlook

For 2026, Jenoptik guided to single‑digit percentage revenue growth versus 2025 and an EBITDA margin in the 19% to 21% range, effectively aiming to return to profitable growth. The company plans CapEx slightly below last year, expects to convert more than 80% of its EUR 591 million backlog, and targets financial results broadly in line with 2025 while managing FX, labor, and refinancing headwinds.

Jenoptik’s earnings call ultimately sketched a transition story, with 2025 marked by lower revenue and earnings but also by heavy lifting on capacity, efficiency, and balance‑sheet strength. Investors will now watch whether strong niches like Biophotonics and Smart Mobility, combined with the new Dresden fab and cost discipline, can drive the profitable growth promised for 2026 and beyond.